Specification not harmonized during submission support – inspection-ready justification strategy






Published on 25/04/2026

Investigation into Non-Harmonized Specifications During Submission Support

The pharmaceutical industry faces continuous challenges in ensuring compliance with regulatory expectations, especially when specifications are not harmonized during submission support. Such deviations can lead to significant hurdles during inspections and may jeopardize product integrity. In this article, we aim to guide pharma professionals through the steps needed to address this issue systematically. By the end of this read, you will be equipped with a clear investigation strategy, capable of identifying root causes and implementing effective corrective actions.

Understanding the symptoms, likely causes, investigation workflow, and subsequent actions are essential in creating an inspection-ready environment. We will delve into each segment systematically, providing practical tools and recommendations to ensure compliance.

Symptoms/Signals on the Floor or in the Lab

A range of signals might indicate that specifications related to raw materials or excipients are not harmonized. Identification of these symptoms swiftly is vital:

  • Variability in Test Results: Repeated out-of-specification (OOS) results for analytical
tests may indicate discrepancies in raw materials.
  • Disparate Specification Parameters: Observing different API quality or excipient compatibility requirements across suppliers.
  • Inconsistent Batch Records: Anomalies in batch release records compared to expected specifications often lead to confusion.
  • Frequent Complaints: Increased customer complaints regarding product performance can signal underlying issues with specification harmonization.
  • Regulatory Questions: Feedback from FDA, EMA, or MHRA concerning submission documents can highlight potential misalignment in specifications.
  • By recognizing these symptoms early, a more proactive approach to investigation can be initiated, minimizing potential repercussions.

    Likely Causes

    Understanding where discrepancies may arise is crucial in defining an effective response strategy. The causes of non-harmonized specifications can be categorized as follows:

    Category Likely Causes
    Materials Inconsistent supplier specifications, differences in the quality of raw materials, and non-compliance with standard pharmacopoeial requirements.
    Method Variation in testing methodologies between sites or laboratories that leads to different outcomes.
    Machine Equipment malfunctions or calibration issues that might produce erroneous data.
    Man (Human Factors) Insufficient training for staff on the latest specifications leading to incorrect documentation or testing procedures.
    Measurement Use of instruments that are not validated for the specific tests or parameters during analysis.
    Environment External factors such as temperature or humidity that might influence raw material properties, fitting into storage issues.

    Documenting the potential causes aids in narrowing down to the root cause and planning the necessary steps for rectification.

    Immediate Containment Actions (first 60 minutes)

    Immediately upon recognizing non-harmonized specifications, it is critical to take containment actions to mitigate risks:

    1. Notification: Alert quality control and quality assurance teams to initiate a preliminary assessment of the situation.
    2. Quarantine Affected Materials: Isolate affected batches to prevent any further processing until a thorough investigation can be completed.
    3. Data Collection: Gather data on all impacted lots, including testing records and batch release documentation, to establish a clear timeline of the events.
    4. Communication: Inform all relevant stakeholders (internal and external) about the ongoing investigation and potential impacts on supply or production.
    5. Initial Assessment: Conduct a preliminary evaluation to determine whether immediate testing can confirm whether the specification misalignment impacts product quality.

    These actions are critical in controlling potential deviations and setting a framework for a more in-depth investigation.

    Investigation Workflow

    The effectiveness of your investigation heavily relies on a well-structured data collection and analysis workflow:

    1. Define Objectives: Clearly document what specific issue you are investigating.
    2. Data Collection: Collect relevant data, including:
      • Raw material certificates of analysis (CoAs)
      • Testing methodologies employed
      • Batch records and historical data on affected materials
      • Supplier specifications and contracts
      • Previous deviations or audit findings related to the supplier in question
      • Environmental monitoring data, if relevant
    3. Data Interpretation: Compare expected vs. actual performance. Identify deviations in testing results that correspond with specifications.
    4. Documentation: Maintain meticulous records of each step in your investigation to ensure traceability and accountability.

    This structured approach provides clarity and focus during the investigation phase, leading to more effective outcomes.

    Root Cause Tools

    Various techniques exist to delve deeper into the root cause analysis of a problem:

    • 5-Why Analysis: This technique helps unravel the initial cause by asking “why” at least five times until the fundamental issue is identified. Best suited for straightforward deviations.
    • Fishbone Diagram: Also known as the Ishikawa diagram, this tool is effective in visualizing the various contributors of a complex issue. It categorizes causes into different areas (Materials, Methods, Machines, etc.) and provides a comprehensive overview of potential causes.
    • Fault Tree Analysis: Used for more complex or critical failures, this method utilizes logic diagrams to explore the possible faults resulting in a failure. It’s particularly useful when the effect can have far-reaching implications.

    Choosing the right tool depends on the complexity of the specifications issue. For straightforward cases, the 5-Why method may suffice, while more systemic problems will benefit from the visual insights provided by a fishbone diagram.

    CAPA Strategy

    Establishing a detailed Corrective and Preventive Action (CAPA) plan is essential once the root cause has been identified:

    • Correction: These are immediate actions taken to rectify the current problem. It may include re-testing materials or re-evaluating materials against the harmonized specifications.
    • Corrective Actions: Actions that will prevent recurrence. This may involve revising supplier specifications, improving staff training, or updating SOPs to better align with regulatory standards.
    • Preventive Actions: Develop proactive measures that ensure that similar discrepancies do not occur in the future, such as enhanced monitoring and quality checks on incoming materials.

    Comprehensive documentation throughout the CAPA process is imperative to demonstrate compliance and readiness for inspections.

    Control Strategy & Monitoring

    A robust control strategy is key in maintaining quality standards post-investigation:

    • Statistical Process Control (SPC): Implement SPC to monitor the manufacturing process and identify trends that could lead to potential specification issues.
    • Regular Sampling Plans: Establish ongoing sampling plans for raw materials and finished products to ensure continued adherence to specifications.
    • Alarm Systems: Use alarms for critical parameters to swiftly inform operators of deviations from defined ranges.
    • Verification Steps: Regularly schedule audits and reviews of supplier performance and compliance to ensure specifications are always in alignment with requirements.

    By maintaining strict controls and monitoring mechanisms, organizations can proactively manage material quality risk and reinforce compliance.

    Validation / Re-qualification / Change Control Impact

    Investigations into non-harmonized specifications may necessitate additional validation or change control activities:

    Related Reads

    • Validation Activities: Depending on the nature of the identified issue, re-validation of processes, equipment, or systems may be required to ensure conformity to specifications.
    • Re-qualification: For critical changes, a complete re-qualification may be required for implicated equipment or analytical methods to confirm their effectiveness under the new specifications.
    • Change Control Procedures: Document any changes made as part of the investigation comprehensively, ensuring compliance with change control requirements to maintain traceability.

    Ensuring that all changes are correctly validated helps prevent future discrepancies and strengthens overall quality management systems.

    Inspection Readiness: What Evidence to Show

    It is critical to assure that your organization is inspection-ready at all times, especially after handling a specification harmonization issue:

    • Records: Maintain comprehensive records documenting the investigations, including findings, analyses, and CAPA implementations.
    • Logs: Document changes made during the CAPA process, detailing who was involved in decision-making and implementation.
    • Batch Documentation: Ensure batch records are complete and correspond to revised specifications accurately.
    • Deviation Reports: Prepare deviation reports for any incidents of non-compliance, inclusive of corrective and preventive actions taken.

    Being transparent and maintaining control over documentation establishes credibility during inspections and reinforces a culture of compliance.

    FAQs

    What should I do first if I suspect a specification is not harmonized?

    Immediately quarantine the affected materials and notify your quality assurance and quality control teams for a preliminary assessment.

    How can I prevent future specification issues?

    Implement regular training sessions for staff, enhance sampling and testing protocols, and maintain robust supplier qualification processes.

    What documentation is essential during an investigation?

    Essential documentation includes raw material CoAs, batch records, supplier specifications, and any relevant deviation reports.

    Is a regulatory authority’s inquiry considered an OOS situation?

    Yes, inquiries or feedback from regulatory bodies like FDA or EMA typically indicate a specification or compliance issue that requires immediate attention.

    What is the role of SPC in controlling specifications?

    SPC helps monitor the manufacturing processes in real-time, enabling detection of trends that could lead to deviations in specifications.

    When is validation necessary after an investigation?

    Validation is necessary when changes impacting the material’s specifications or processing methods are made, requiring confirmation they meet regulatory standards.

    What is the 5-Why analysis?

    The 5-Why analysis is a problem-solving tool that involves asking “why” multiple times to drill down to the root cause of a deviation.

    How often should supplier specifications be reviewed?

    Regular reviews—ideally semi-annually or annually—should be conducted to ensure compliance with evolving regulatory requirements and internal standards.

    How do I ensure a CAPA is effective?

    To ensure CAPA effectiveness, regularly review the actions taken, monitor their outcomes, and adjust as necessary to prevent recurrence.

    Is an external audit necessary?

    Yes, external audits can provide an impartial evaluation of your processes and quality systems, ensuring compliance and uncovering potential risks.

    What implications do non-harmonized specifications have on FDA inspections?

    Non-harmonized specifications can lead to questions during FDA inspections, potentially resulting in warnings, fines, or necessary changes to production practices.

    What are common challenges with supplier compliance?

    Common challenges include variability in quality, lack of timely communication, and disagreements on specification definitions leading to misalignment.

    What tools are best suitable for complex investigations?

    Fishbone diagrams and Fault Tree Analysis are best for complex investigations, allowing teams to visualize numerous contributing factors systematically.

    Pharma Tip:  Specification not harmonized during inspection – CAPA for compendial failures